Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy [Phase 3]
Phase III trial of Lucanix in advanced non-small cell lung cancer following front-line chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)
This completed observational pilot trial evaluated the feasibility of conducting genome-wide association studies using subject-provided info…
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a dose-escalation study of TH-302 in combination with gemcitabine, docetaxel, or pemetr…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial update examining EF5 as a biomarker to assess tumor response to anticancer therapy in patients with stage I-III non-small ce…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
A terminated clinical trial update studying soluble and cellular biomarkers and functional imaging during antiangiogenic therapies in cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating WST11 in patients with obstructing endobronchial non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer [Phase 3]
A Phase 3 trial of Acetyl-L-carnitine in combination with a cisplatin-containing chemotherapy as first-line treatment for advanced or metast…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib [Phase 2]
Phase 2 trial update on erlotinib re-challenge in patients with recurrent EGFR-mutant non-small cell lung cancer who previously received adj…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating Polyphenon E in addition to Erlotinib for advanced non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer [Phase 2]
Completed Phase 2 clinical trial evaluating EF5 as a marker of tumor hypoxia in patients with stage I-III non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC [Phase 3]
A Phase 3 trial comparing prophylactic cranial irradiation to observation in stage III non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC [Phase 1]
Phase 1 study reports safety, tolerability, and pharmacokinetics of multiple ascending doses of Simotinib Hydrochloride in patients with adv…
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A completed Phase 1b/2 trial in Asian subjects with non-small cell lung cancer, reporting progress and results from the study.
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC] [Phase 1]
The Phase 1 study of Debio 0932 in combination with standard of care for non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer [Phase 2]
A Phase 2 trial assessing erlotinib plus docetaxel as second-line therapy for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating fosaprepitant for prevention of chemotherapy-induced vomiting in patients with advanced non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating sequential use of Tarceva (erlotinib) with Gemcitabine as first-line therapy for advanced non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression [Phase 4]
Phase 4 study of Tarceva (erlotinib) in locally advanced or metastatic non-small cell lung cancer after four cycles of platinum-based chemot…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer [Phase 1]
Phase 1 study evaluating the combination of crizotinib and neratinib in non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing paclitaxel/carboplatin with PF-3512676 versus paclitaxel/carboplatin alone in advanced non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Tarceva. ICORG 08-41
A completed clinical trial update for ICORG 08-41 evaluating erlotinib (Tarceva) in non-small cell lung cancer, sponsored by Cancer Trials I…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC [Phase 3]
Phase 3 randomized trial comparing gemcitabine/cisplatin with PF-3512676 vs without PF-3512676 in advanced non-small cell lung cancer was te…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial by the Radiation Therapy Oncology Group evaluating the combination of radiation therapy and chemotherapy for non-small cell …
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating intrapleural bevacizumab and cisplatin for malignant pleural effusion caused by non-small cell lung cancer has co…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating laboratory-treated autologous lymphocytes with aldesleukin and GM-CSF for recurrent, refractory, or metastatic non-…